| Detected | Trial | Change |
|---|---|---|
| 2026-06-10 | NCT06176352 A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal… |
Trial completed |
| 2026-05-29 | NCT07403825 Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material |
Recruitment opened |
| 2026-05-29 | NCT07403825 Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material |
Trial sites expanded: 0 -> 10 locations |
| 2026-05-19 | NCT06790784 Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR |
Trial sites expanded: 20 -> 27 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07403825 | Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material | Macular Degeneration, Age Related | Recruiting |
| NCT05610319 | Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular… | Diabetic Macular Edema | Active, Not Recruiting |
| NCT06795048 | A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants… | Neovascular Age-related Macular Degeneration (nAMD) | Active, Not Recruiting |
| NCT05224102 | A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented… | Diabetic Macular Edema | Active, Not Recruiting |
| NCT06191094 | Pre-operative Vabysmo in Patients With Non-clearing Vitreous Hemorrhage Secondary to… | Diabetic Retinopathy | Enrolling by Invitation |
| Phase 3 | |||
| NCT05844982 | Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal… | Radiation Retinopathy | Recruiting |
| NCT06790784 | Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR | Proliferative Diabetic Retinopathy (PDR) | Recruiting |
| Phase 2 | |||
| NCT06908876 | A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular… | Diabetic Macular Oedema | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06850922 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603… | Diabetic Macular Edema | Active, Not Recruiting |
| Phase 1 | |||
| NCT07425522 | A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of… | Diabetic Macular Edema | Recruiting |
| Not specified | |||
| NCT07520045 | Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab | Diabetic Retinopathy (DR) | Recruiting |
| NCT06680817 | A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study) | Neovascular Age-related Macular Degeneration | Recruiting |
| NCT06439576 | Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein… | Diabetic Macular Edema | Active, Not Recruiting |
| NCT05476926 | A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products | Neovascular Age-related Macular Degeneration | Active, Not Recruiting |